CAS 155206-00-1
:Bimatoprost
- (5E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
- (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide
- (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
- (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
- 17-Phenyl-Tri-Norprostaglandin F2Α-Ethyl Amide
- 17-Phenyltrinor-PGF2α ethylamide
- 17-phenyl TRINOR prostaglandin F2ALPHA ethyl amide
- 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5Z)-
- 5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-, (5Z)-
- 5-Heptenamide, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-, [1R-[1α(Z),2β(1E,3S*),3α,5α]]-
- Agn 192024
- Bimatoprost(LUMIGAN)
- Bimatoprost(TM)
- Latisse
- Lumigan
- N-Ethyl-9Alpha,11Alpha,15S-Trihydroxy-17-Phenyl-18,19,20-Trinor-Prosta-5Z, 13E-Dien-1-Amide
- Prostamide
- See more synonyms
Bimatoprost
CAS:Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormula:C25H37NO4Color and Shape:White Off-White PowderMolecular weight:415.272265-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-, (5Z)-
CAS:Formula:C25H37NO4Purity:98%Color and Shape:SolidMolecular weight:415.5656Bimatoprost, min. 98%
CAS:Formula:C25H37NO4Purity:min. 98%Color and Shape:White to Off-white PowderMolecular weight:415.57Bimatoprost
CAS:Formula:C25H37NO4Purity:≥ 97.0%Color and Shape:White or off-white crystalline powder or crystalsMolecular weight:415.57Bimatoprost
CAS:Bimatoprost (AGN 192024) is a cloprostenol-derived amide that is used as an antihypertensive agent in the treatment of open-angle glaucoma and ocularFormula:C25H37NO4Purity:98% - >99.99%Color and Shape:Crystalline SolidMolecular weight:415.57Ref: TM-T2538
2mg34.00€5mg48.00€10mg75.00€25mg127.00€50mg219.00€100mg371.00€200mg547.00€1mL*10mM (DMSO)50.00€Bimatoprost
CAS:Stability Light Sensitive
Applications Bimatoprost is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α.
References Brandt, J.D., et al.: Ophthalmology, 108, 1023 (2001), Woodward, D.F., et al.: J. Pharmacol. Exp. Ther., 305, 772 (2003), Quinones, R., et al.: J. Ocul. Pharmacol. Ther., 20, 115 (2004),Formula:C25H37NO4Color and Shape:WhiteMolecular weight:415.57Bimatoprost-d5
CAS:Controlled ProductApplications Labelled Bimatoprost (B386800). Bimatoprost is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α.
References Brandt, J.D., et al.: Ophthalmology, 108, 1023 (2001), Woodward, D.F., et al.: J. Pharmacol. Exp. Ther., 305, 772 (2003), Quinones, R., et al.: J. Ocul. Pharmacol. Ther., 20, 115 (2004),Formula:C25H32D5NO4Color and Shape:NeatMolecular weight:420.6Bimatoprost
CAS:A potent prostanoid receptor (FP) agonist and PGF2α analog. Its biological activity is mediated by action on prostamide receptors. Has therapeutic potential for glaucoma and ocular hypertension.Formula:C25H37NO4Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:415.57 g/molBimatoprost
CAS:Formula:C25H37NO4Purity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:415.57Bimatoprost Acid Ethyl Ester
CAS:Controlled ProductApplications Bimatoprost Acid Ethyl Ester is an impurity of Bimatoprost (B386800). Bimatoprost is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α.
References Brandt, J.D., et al.: Ophthalmology, 108, 1023 (2001), Woodward, D.F., et al.: J. Pharmacol. Exp. Ther., 305, 772 (2003), Quinones, R., et al.: J. Ocul. Pharmacol. Ther., 20, 115 (2004),Formula:C25H36O5Color and Shape:NeatMolecular weight:416.55












